Mircera
Mircera ingredients
| Active ingredient | Strength |
|---|---|
| Methoxy Polyethylene Glycol-Epoetin Beta | 200 ug/.3mL, 30 ug/.3mL, 120 ug/.3mL, 150 ug/.3mL, 100 ug/.3mL, 250 ug/.3mL |
What Mircera is used for
Mircera is a specialist medicine (erythropoiesis-stimulating agent). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Mircera
- Generic name
- Methoxy polyethylene glycol-epoetin beta
- Made by
- Vifor (International) Inc.
- Forms
- Injection, Solution
- Given
- Intravenous
- Drug class
- Erythropoiesis-stimulating Agent
- FDA approval
- Biologic licence (BLA) BLA125164
- On the US market since
- 2014
Official information
- Mircera prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Methoxy polyethylene glycol-epoetin beta)
In India
- Methoxy polyethylene glycol-epoetin beta: 2 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Mircera?
Mircera (Methoxy polyethylene glycol-epoetin beta) is a specialist medicine made by Vifor (International) Inc., approved by the US FDA.
What are the ingredients of Mircera?
Mircera contains Methoxy Polyethylene Glycol-Epoetin Beta (200 ug/.3mL, 30 ug/.3mL, 120 ug/.3mL, 150 ug/.3mL, 100 ug/.3mL, 250 ug/.3mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA